APA

Reis-Mendes A., Gomes A. S., Carvalho R. A., Carvalho F., Remião F., Pinto M., Bastos M. L., Sousa E. & Costa V. M. (20170911). Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy. : Archives of toxicology.

Chicago

Reis-Mendes A, Gomes A S, Carvalho R A, Carvalho F, Remião F, Pinto M, Bastos M L, Sousa E and Costa V M. 20170911. Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy. : Archives of toxicology.

Harvard

Reis-Mendes A., Gomes A. S., Carvalho R. A., Carvalho F., Remião F., Pinto M., Bastos M. L., Sousa E. and Costa V. M. (20170911). Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy. : Archives of toxicology.

MLA

Reis-Mendes A, Gomes A S, Carvalho R A, Carvalho F, Remião F, Pinto M, Bastos M L, Sousa E and Costa V M. Naphthoquinoxaline metabolite of mitoxantrone is less cardiotoxic than the parent compound and it can be a more cardiosafe drug in anticancer therapy. : Archives of toxicology. 20170911.